PT  - JOURNAL ARTICLE
AU  - Janet L. Fisher
AU  - Jie Zhang
AU  - Robert L. Macdonald
TI  - The Role of α1 and α6 Subtype Amino-Terminal Domains in Allosteric Regulation of γ-Aminobutyric Acid<sub>a</sub> Receptors
AID  - 10.1124/mol.52.4.714
DP  - 1997 Oct 01
TA  - Molecular Pharmacology
PG  - 714--724
VI  - 52
IP  - 4
4099  - http://molpharm.aspetjournals.org/content/52/4/714.short
4100  - http://molpharm.aspetjournals.org/content/52/4/714.full
SO  - Mol Pharmacol1997 Oct 01; 52
AB  - The γ-aminobutyric acidA (GABA) receptor in the mammalian central nervous system is composed of pentameric combinations of α1–6, β1–4, γ1–3, δ1, and/or ε1 subunit subtypes. Although each of the different subunits influences the functional properties of γ-aminobutyric acidA receptors (GABARs), the α subunit subtypes have been shown to be important for activation of the receptor by GABA and pentobarbital and the regulation of GABARs by numerous allosteric regulators, including benzodiazepines, furosemide, zinc, and lanthanum. However, with the exception of the benzodiazepines, the α subtype domain that is responsible for the action of these allosteric compounds is unknown. The α1 and α6 subtypes are among the most diverse of the α subunit family and confer a different responsiveness of GABARs to GABA and many of the allosteric modulators. These regulatory compounds act after extracellular application and therefore likely act on extracellular GABAR sites, the largest of which is the amino-terminal extracellular domain. To determine the role of this domain in the action of these allosteric regulatory agents, we constructed chimeras of the rat α1 and α6 subtypes with a splice site within the first putative transmembrane domain (TM). This separated the large extracellular amino-terminal domain from the transmembrane, intracellular, and TM2–3 and carboxyl-terminal extracellular domains of the subunit. The chimeric subtypes were expressed in L929 fibroblasts along with β3 and γ2L subtypes, and their pharmacological properties were determined with whole-cell electrophysiological recording. The α subtype amino-terminal extracellular domain was the primary determinant of GABA sensitivity and was responsible for the functional properties of activation by pentobarbital, sensitivity to diazepam, potentiation by lanthanum, and high affinity inhibition by furosemide. The remaining carboxyl-terminal domains influenced the GABA sensitivity and determined zinc sensitivity and low affinity inhibition by furosemide. Both domains were apparently required for inhibition by lanthanum.